» Articles » PMID: 18687466

The Functional Role of the Renin-angiotensin System in Pregnancy and Preeclampsia

Overview
Journal Placenta
Publisher Elsevier
Date 2008 Aug 9
PMID 18687466
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

During normal pregnancy, the renin-angiotensin system (RAS) plays a vitally important role in salt balance and subsequent well-being of mother and fetus. In this balance, one must consider not only the classical renal RAS but also that of the uteroplacental unit, where both maternal and fetal tissues contribute to the signaling cascade. Many studies have shown that in normal pregnancy there is an increase in almost all of the components of the RAS. In derangements of pregnancy this delicate equilibrium can become unbalanced. Preeclampsia is one such case. It is a disorder of pregnancy characterized by hypertension, proteinuria and placental abnormalities associated with shallow trophoblast invasion and impaired spiral artery remodeling. Despite being a leading cause of maternal death and a major contributor to maternal and perinatal morbidity, the mechanisms responsible for the pathogenesis of preeclampsia are poorly understood. Immunological mechanisms and the RAS have been long considered to be involved in the development of preeclampsia. Numerous recent studies demonstrate the presence of the angiotensin II type I receptor agonistic autoantibody (AT1-AA). This autoantibody can induce many key features of the disorder and upregulate molecules involved in the pathogenesis of preeclampsia. Here we review the functional role of the RAS during pregnancy and the impact of AT1-AA on preeclampsia.

Citing Articles

Diagnostic and therapeutic approaches to a case of pregnancy complicated by bilateral adrenocortical adenomas with primary aldosteronism and Cushing's syndrome.

Chen Y, Tan L, Chen T, Tian H, Li L, Ren Y Endocrine. 2024; 87(2):822-829.

PMID: 39375255 PMC: 11811435. DOI: 10.1007/s12020-024-04058-x.


Importance of the (Pro)renin Receptor in Activating the Renin-Angiotensin System During Normotensive and Preeclamptic Pregnancies.

Schofield L, Endacott S, Delforce S, Lumbers E, Pringle K Curr Hypertens Rep. 2024; 26(12):483-495.

PMID: 39093387 PMC: 11455731. DOI: 10.1007/s11906-024-01316-1.


Behind the Curtain of Abnormal Placentation in Pre-Eclampsia: From Molecular Mechanisms to Histological Hallmarks.

Gusella A, Martignoni G, Giacometti C Int J Mol Sci. 2024; 25(14).

PMID: 39063129 PMC: 11277090. DOI: 10.3390/ijms25147886.


Gestationally administered RAS modulators reprogram endotoxic cardiovascular and inflammatory profiles in adult male offspring of preeclamptic rats.

Abuiessa S, Helmy M, El-Gowelli H, El-Gowilly S, El-Mas M Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(1):699-713.

PMID: 39046530 DOI: 10.1007/s00210-024-03305-2.


Pathophysiology of Preeclampsia-Induced Vascular Dysfunction and Implications for Subclinical Myocardial Damage and Heart Failure.

Shaw L, Patel K, Lala-Trindade A, Feltovich H, Vieira L, Kontorovich A JACC Adv. 2024; 3(6):100980.

PMID: 38938863 PMC: 11198310. DOI: 10.1016/j.jacadv.2024.100980.


References
1.
Pearce S, Merriman T . Genetic progress towards the molecular basis of autoimmunity. Trends Mol Med. 2006; 12(2):90-8. DOI: 10.1016/j.molmed.2005.12.005. View

2.
Caniggia I, Kuliszewsky M, Post M, Lye S . Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest. 1999; 103(12):1641-50. PMC: 408387. DOI: 10.1172/JCI6380. View

3.
Urata H, Kinoshita A, Misono K, BUMPUS F, Husain A . Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem. 1990; 265(36):22348-57. View

4.
Karumanchi S, Bdolah Y . Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question. Endocrinology. 2004; 145(11):4835-7. DOI: 10.1210/en.2004-1028. View

5.
Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A . Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999; 103(7):945-52. PMC: 408252. DOI: 10.1172/JCI4106. View